Cargando…

Structural brain imaging in Alzheimer’s disease and mild cognitive impairment: biomarker analysis and shared morphometry database

Magnetic resonance (MR) imaging is a powerful technique for non-invasive in-vivo imaging of the human brain. We employed a recently validated method for robust cross-sectional and longitudinal segmentation of MR brain images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. Specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ledig, Christian, Schuh, Andreas, Guerrero, Ricardo, Heckemann, Rolf A., Rueckert, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062561/ https://www.ncbi.nlm.nih.gov/pubmed/30050078 http://dx.doi.org/10.1038/s41598-018-29295-9

Ejemplares similares

Automatic morphometry in Alzheimer's disease and mild cognitive impairment()()
por: Heckemann, Rolf A., et al.
Publicado: (2011)

Learning Biomarker Models for Progression Estimation of Alzheimer’s Disease
por: Schmidt-Richberg, Alexander, et al.
Publicado: (2016)

An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease
por: Schmitter, Daniel, et al.
Publicado: (2014)

Longitudinal changes in surface based brain morphometry measures in amnestic mild cognitive impairment and Alzheimer’s Disease
por: Bachmann, Tobias, et al.
Publicado: (2023)

Brain Extraction Using Label Propagation and Group Agreement: Pincram
por: Heckemann, Rolf A., et al.
Publicado: (2015)

Correction: Brain Extraction Using Label Propagation and Group Agreement: Pincram
por: Heckemann, Rolf A., et al.
Publicado: (2015)

Voxel-based morphometry in Alzheimers disease and mild cognitive impairment: Systematic review of studies addressing the frontal lobe
por: Ribeiro, Luís Gustavo, et al.
Publicado: (2016)

Topographical Disorientation in Mild Cognitive Impairment: A Voxel-Based Morphometry Study
por: Lim, Tae-Sung, et al.
Publicado: (2010)

Impact of Amyloid Pathology in Mild Cognitive Impairment Subjects: The Longitudinal Cognition and Surface Morphometry Data
por: Chang, Hsin-I, et al.
Publicado: (2022)

Erratum: Topographical Disorientation in Mild Cognitive Impairment: A Voxel-Based Morphometry Study
Publicado: (2011)

A Comparative Atlas-Based Recognition of Mild Cognitive Impairment With Voxel-Based Morphometry
por: Long, Zhuqing, et al.
Publicado: (2018)

Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment
por: Martínez-Torteya, Antonio, et al.
Publicado: (2015)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
por: Garcia Condado, Jorge, et al.
Publicado: (2023)

Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease
por: Popescu, Sebastian G., et al.
Publicado: (2020)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer’s Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry
por: Li, Kaidi, et al.
Publicado: (2022)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

Regional brain morphometry in patients with traumatic brain injury based on acute- and chronic-phase magnetic resonance imaging
por: Ledig, Christian, et al.
Publicado: (2017)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Using Voxel-Based Morphometry to Examine the Relationship between Regional Brain Volumes and Memory Performance in Amnestic Mild Cognitive Impairment
por: Meyer, Patric, et al.
Publicado: (2013)

Cognitive Profiles of Patients with Mild Cognitive Impairment or Dementia in Alzheimer's or Parkinson's Disease
por: Hildebrandt, Helmut, et al.
Publicado: (2013)

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017)

Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer’s disease
por: Lad, Eleonora M., et al.
Publicado: (2018)

Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease
por: Tao, Rui, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
por: Zhao, Aonan, et al.
Publicado: (2020)

Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer’s disease and mild cognitive impairment
por: Castellazzi, Massimiliano, et al.
Publicado: (2019)

Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease
por: Oviedo, Diana C., et al.
Publicado: (2018)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
por: Arenare, Giulia, et al.
Publicado: (2023)

Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m9n0ponj6ubdvqjggstviji36l